<unk>  is a carbonic anhydrase inhibitor that is FDA approved for the {{{indicationType}}} of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.   Common adverse reactions include taste alteration, hypersensitivity reaction, punctate keratitis, and visual discomfort.
Dorzolamide
Methazolamide
Brinzolamide
Tramazoline
Trimazosin
Clopamide
Prazosin
Felodipine